Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Centessa Pharmaceuticals plc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +24 vs. Q2 2024
- Shares held
- 108.6M
- +22.5M (+26.2%) vs. Q2 2024
- Total value
- $1.74B
- +$960.5M (+123.6%) vs. Q2 2024
- New holders
- 32
- 44 more added
- Sold out
- 8
- 16 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 6,282,290 | $100.5M | 2.16% | +2,348,983+59.7% | Added |
| General Atlantic LLC | 9,681,818 | $154.8M | 4.40% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $319.2M | 60.35% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −2,112,500−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −87,210−100.0% | Sold out |
| Vestcor Inc | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −9,608−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −520−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −407−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |